Hassan Dianat-Moghadam

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Cancer Stem Cells

Silver Nanoparticles

Top Venues

Medical oncology (Northwood, London, England)

Bioprocess and biosystems engineering

This page only lists publications with an associated author ORCID identifier.

Publications

Alireza Ghannad Sabzevari, Hossein Sabahi, Mohsen Nikbakht, Mehdi Azizi, Hassan Dianat-Moghadam, Zohreh Amoozgar
Exploring the Potential of Montmorillonite as an Antiproliferative Nanoagent against MDA-MB-231 and MCF-7 Human Breast Cancer Cells. Cells 13 (2) (2024)
Alireza Ghannad Sabzevari, Hossein Sabahi, Mohsen Nikbakht, Mehdi Azizi, Hassan Dianat-Moghadam, Zohreh Amoozgar
Exploring the Potential of Montmorillonite as an Antiproliferative Nanoagent against MDA-MB-231 and MCF-7 Human Breast Cancer Cells. Cells 13 (2) (2024)
Alireza Ghannad Sabzevari, Hossein Sabahi, Mohsen Nikbakht, Mehdi Azizi, Hassan Dianat-Moghadam, Zohreh Amoozgar
Exploring the Potential of Montmorillonite as an Antiproliferative Nanoagent against MDA-MB-231 and MCF-7 Human Breast Cancer Cells. Cells 13 (2) (2024)
Alireza Ghannad Sabzevari, Hossein Sabahi, Mohsen Nikbakht, Mehdi Azizi, Hassan Dianat-Moghadam, Zohreh Amoozgar
Exploring the Potential of Montmorillonite as an Antiproliferative Nanoagent against MDA-MB-231 and MCF-7 Human Breast Cancer Cells. Cells 13 (2) (2024)
Hassan Dianat-Moghadam, Soheil Abbasspour-Ravasjani, Hamed Hamishehkar, Reza Rahbarghazi, Mahammad Nouri
LXR inhibitor SR9243-loaded immunoliposomes modulate lipid metabolism and stemness in colorectal cancer cells. Medical oncology (Northwood, London, England) 40 (6) (2023)
Hassan Dianat-Moghadam, Soheil Abbasspour-Ravasjani, Hamed Hamishehkar, Reza Rahbarghazi, Mahammad Nouri
LXR inhibitor SR9243-loaded immunoliposomes modulate lipid metabolism and stemness in colorectal cancer cells. Medical oncology (Northwood, London, England) 40 (6) (2023)
Hassan Dianat-Moghadam, Soheil Abbasspour-Ravasjani, Hamed Hamishehkar, Reza Rahbarghazi, Mahammad Nouri
LXR inhibitor SR9243-loaded immunoliposomes modulate lipid metabolism and stemness in colorectal cancer cells. Medical oncology (Northwood, London, England) 40 (6) (2023)
Hassan Dianat-Moghadam, Soheil Abbasspour-Ravasjani, Hamed Hamishehkar, Reza Rahbarghazi, Mahammad Nouri
LXR inhibitor SR9243-loaded immunoliposomes modulate lipid metabolism and stemness in colorectal cancer cells. Medical oncology (Northwood, London, England) 40 (6) (2023)
Hassan Dianat-Moghadam, Soheil Abbasspour-Ravasjani, Hamed Hamishehkar, Reza Rahbarghazi, Mahammad Nouri
LXR inhibitor SR9243-loaded immunoliposomes modulate lipid metabolism and stemness in colorectal cancer cells. Medical oncology (Northwood, London, England) 40 (6) (2023)
Hassan Dianat-Moghadam, Amir Mahari, Reza Salahlou, Mostafa Khalili, Mehdi Azizi, Hadi Sadeghzadeh
Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy. Stem cell research & therapy 13 (1) (2022)
Morteza Yadi, Mehdi Azizi, Hassan Dianat-Moghadam, Abolfazl Akbarzadeh, Morteza Abyadeh, Morteza Milani
Antibacterial activity of green gold and silver nanoparticles using ginger root extract. Bioprocess and biosystems engineering 45 (12) (2022)
Mehdi Shahgolzari, Hassan Dianat-Moghadam, Afagh Yavari, Steven N Fiering, Kathleen L Hefferon
Multifunctional Plant Virus Nanoparticles for Targeting Breast Cancer Tumors. Vaccines 10 (9) (2022)
Reza Mahmoudi, Hassan Dianat-Moghadam, Mansour Poorebrahim, Samaneh Siapoush, Vahdat Poortahmasebi, Reza Salahlou, Mohammad Rahmati
Recombinant immunotoxins development for HER2-based targeted cancer therapies. Cancer cell international 21 (1) (2021)